Literature DB >> 1967516

Neuromuscular and cardiovascular effects of high-dose vecuronium.

W C Tullock1, P Diana, D R Cook, D H Wilks, B W Brandom, R L Stiller, C A Beach.   

Abstract

The effects of bolus administration of large doses of vecuronium on the onset and duration of neuromuscular blockade and histamine release were studied during fentanyl-nitrous oxide anesthesia. Forty adults were randomly assigned to receive a bolus injection of either 0.1, 0.2, 0.3, or 0.4 mg/kg of vecuronium. The evoked electromyogram of thumb adduction to train-of-four stimulation was monitored. The time of onset and clinical duration (mean +/- SEM) after each dose were as follows: 0.1 mg/kg, 164 +/- 27 s and 42 +/- 5 min; 0.2 mg/kg, 120 +/- 17 s and 68 +/- 8 min; 0.3 mg/kg, 88 +/- 17 s and 111 +/- 19 min; 0.4 mg/kg, 78 +/- 19 s and 115 +/- 19 min. Both time of onset and duration after doses of 0.3 or 0.4 mg/kg were significantly different from values after the lower doses. No dose-related changes in blood pressure, heart rate, or histamine release were observed. The authors conclude that large bolus doses of vecuronium can be safely used to speed the onset of blockade, but with a significantly prolonged duration of action.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1967516     DOI: 10.1213/00000539-199001000-00015

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  9 in total

Review 1.  Newer neuromuscular blocking agents: how do they compare with established agents?

Authors:  H J Sparr; T M Beaufort; T Fuchs-Buder
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Investigation of the cardiac effects of pancuronium, rocuronium, vecuronium, and mivacurium on the isolated rat atrium.

Authors:  Sinan Gursoy; Ihsan Bagcivan; Nedim Durmus; Kenan Kaygusuz; Iclal Ozdemir Kol; Cevdet Duger; Sahin Yildirim; Caner Mimaroglu
Journal:  Curr Ther Res Clin Exp       Date:  2011-10

3.  Evaluation of cisatracurium, a new neuromuscular blocking agent, for tracheal intubation.

Authors:  L S Bluestein; L W Stinson; R L Lennon; S N Quessy; R M Wilson
Journal:  Can J Anaesth       Date:  1996-09       Impact factor: 5.063

4.  High-dose vecuronium neuromuscular block: a comparison of arrhythmias and onset of block during sufentanil anaesthesia.

Authors:  M D Sharpe; J M Murkin; T Vannelli
Journal:  Can J Anaesth       Date:  1995-08       Impact factor: 5.063

Review 5.  Neuromuscular transmission and its pharmacological blockade. Part 1: Neuromuscular transmission and general aspects of its blockade.

Authors:  L H Booij
Journal:  Pharm World Sci       Date:  1997-02

6.  Duration of action of supplemental doses of vecuronium is related to the duration after the initial dose.

Authors:  T Otagiri; M Narita; M Nishizawa; C Nishimura
Journal:  J Anesth       Date:  1992-04       Impact factor: 2.078

7.  Rapid tracheal intubation with atracurium: the timing principle.

Authors:  K F Koh; F G Chen
Journal:  Can J Anaesth       Date:  1994-08       Impact factor: 5.063

Review 8.  The use of muscle relaxants in the intensive care unit.

Authors:  M D Sharpe
Journal:  Can J Anaesth       Date:  1992-11       Impact factor: 5.063

Review 9.  Anesthetic considerations in pediatric mastocytosis: a review.

Authors:  Norma J Klein; Shad Misseldine
Journal:  J Anesth       Date:  2013-02-14       Impact factor: 2.078

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.